APA

Holkova B., Kmieciak M., Bose P., Yazbeck V. Y., Barr P. M., Tombes M. B., Shrader E., Weir-Wiggins C., Rollins A. D., Cebula E. M., Pierce E., Herr M., Sankala H., Hogan K. T., Wan W., Feng C., Peterson D. R., Fisher R. I., Grant S. & Friedberg J. W. (20161213). Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas. : Leukemia & lymphoma.

Chicago

Holkova Beata, Kmieciak Maciej, Bose Prithviraj, Yazbeck Victor Y, Barr Paul M, Tombes Mary Beth, Shrader Ellen, Weir-Wiggins Caryn, Rollins April D, Cebula Erin M, Pierce Emily, Herr Megan, Sankala Heidi, Hogan Kevin T, Wan Wen, Feng Changyong, Peterson Derick R, Fisher Richard I, Grant Steven and Friedberg Jonathan W. 20161213. Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas. : Leukemia & lymphoma.

Harvard

Holkova B., Kmieciak M., Bose P., Yazbeck V. Y., Barr P. M., Tombes M. B., Shrader E., Weir-Wiggins C., Rollins A. D., Cebula E. M., Pierce E., Herr M., Sankala H., Hogan K. T., Wan W., Feng C., Peterson D. R., Fisher R. I., Grant S. and Friedberg J. W. (20161213). Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas. : Leukemia & lymphoma.

MLA

Holkova Beata, Kmieciak Maciej, Bose Prithviraj, Yazbeck Victor Y, Barr Paul M, Tombes Mary Beth, Shrader Ellen, Weir-Wiggins Caryn, Rollins April D, Cebula Erin M, Pierce Emily, Herr Megan, Sankala Heidi, Hogan Kevin T, Wan Wen, Feng Changyong, Peterson Derick R, Fisher Richard I, Grant Steven and Friedberg Jonathan W. Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas. : Leukemia & lymphoma. 20161213.